Minocycline
Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as pneumonia. It is generally (but not always) less preferred than the tetracycline doxycycline. Minocycline is also used for the treatment of acne and rheumatoid arthritis. It is taken by mouth or applied to the skin.
Clinical data | |
---|---|
Trade names | Minocin, Amzeeq, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682101 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, intravenous, topical |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90–100% |
Protein binding | 70–75% |
Metabolism | Liver |
Elimination half-life | 14–22 (11–26) hours |
Excretion | Mostly fecal, 10–15% renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.226.626 |
Chemical and physical data | |
Formula | C23H27N3O7 |
Molar mass | 457.483 g·mol−1 |
3D model (JSmol) | |
Specific rotation | = −166° |
Solubility in water | Low |
| |
| |
(what is this?) (verify) |
Common side effects include nausea, diarrhea, dizziness, allergic reactions, and kidney problems. Serious side effects may include anaphylaxis, a lupus-like syndrome, and easy sunburning. Use in the later part of pregnancy may harm the baby and safety during breastfeeding is unclear. It works by decreasing a bacterium's ability to make protein thus stopping its growth.
Minocycline was patented in 1961 and came into commercial use in 1971. It is available as a generic medication. In 2020, it was the 236th most commonly prescribed medication in the United States, with more than 1 million prescriptions.